Xia Yi, Wang Dianyu, Jia Haixue, Wang Zhilong, Chen Yongxia, Zhang Youtian, Fan Jiaming, Gui Han, Mu Ganen, Guan Yong, Wu Yuanhao, Liu Jinjian, Liu Jianfeng
State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Tianjin Institutes of Health Science, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
Tianjin Center for Medical Device Evaluation and Inspection, Tianjin, 300191, China.
Mater Today Bio. 2025 May 29;32:101916. doi: 10.1016/j.mtbio.2025.101916. eCollection 2025 Jun.
Postoperative recurrence and metastasis of breast cancer is the leading cause of death. Radiotherapy is the standard procedure after breast cancer operation. The radiation-induced abscopal effect (RIAE) exhibited tremendous therapeutic efficacy for distant tumor metastasis, but the limited radiation dose and the postoperative immunosuppression leads to unsatisfied clinical efficiency. In this study, we developed a γ-ray responsive injectable hydrogel through selenide-based Schiff crosslinks and provided the proof-of-principle evidence of radiation-induced immunity activation strategy through RIAE for postoperative breast cancer recurrence and metastasis. The irradiated tumor cell membrane by high dose of γ-ray is served as an "antigen reservoir" and loaded into the γ-ray responsive biodegradable hydrogel to construct a radiation-activated "blasting fuse". Once upon the radiotherapy, the radio-responsive hydrogel "blasting fuse" could be boomed for triggered release of the encapsulated "antigen reservoir" and other immunomodulators by the accelerated degradation due to radiation-induced cleavage of diselenium bond. In mice model, the immune defense for tumor could be activated by γ-ray irradiation of radiotherapy, thus contributing to an efficient prevention of postoperative breast cancer recurrence and metastasis through radio-immunotherapy. This novel strategy points out a new inspiration for immunostimulatory activation of immune cold tumor and postoperative inhibition of tumor recurrence and metastasis.
乳腺癌术后复发和转移是主要的死亡原因。放射治疗是乳腺癌手术后的标准治疗手段。辐射诱导的远隔效应(RIAE)对远处肿瘤转移显示出巨大的治疗效果,但辐射剂量有限以及术后免疫抑制导致临床疗效不尽人意。在本研究中,我们通过基于硒化物的席夫交联开发了一种γ射线响应性可注射水凝胶,并提供了通过RIAE激活免疫以预防乳腺癌术后复发和转移的原理性证据。高剂量γ射线照射的肿瘤细胞膜作为“抗原库”,被装载到γ射线响应性可生物降解水凝胶中,构建一个辐射激活的“爆破引信”。一旦进行放射治疗,放射响应性水凝胶“爆破引信”会因辐射诱导的二硒键断裂而加速降解,从而引发释放封装的“抗原库”和其他免疫调节剂。在小鼠模型中,放射治疗的γ射线照射可激活针对肿瘤的免疫防御,从而通过放射免疫疗法有效预防乳腺癌术后复发和转移。这种新策略为免疫冷肿瘤的免疫刺激激活以及术后肿瘤复发和转移的抑制指出了新的思路。